AMPK activators – potential therapeutics for metabolic and other diseases
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
AMP‐activated protein kinase (AMPK)‐mediated cellular metabolic responses to tissue‐specific and whole‐body stimuli play a vital role in the control of energy homeostasis. As a cellular energy‐sensing mechanism, AMPK activation stimulates glucose uptake and fat oxidation, while it suppresses lipogenesis and gluconeogenesis. The cumulative effects of AMPK activation lead to beneficial metabolic states in liver, muscle and other peripheral tissues that are critical in the pathogenesis of obesity, type 2 diabetes and related metabolic disorders. Activators of AMPK that target selected tissues hold potential as novel therapeutics for diseases in which altered energy metabolism contributes to aetiology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α
Jäger, S., Handschin, C., St.-Pierre, J., & Spiegelman, B. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705070104 · Cited by 2,491
Dysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
Kelley, D. E., He, J., Menshikova, E. V., & Ritov, V. B. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2944 · Cited by 2,321
Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193 · cited 1×
“Second, defects in skeletal muscle mitochondrial capacity and fatty acid metabolism may be responsible for intramyocellular lipid accumulation and insulin resistance (Kelley et al. 2002, Petersen et al. 2004).”
BackgroundOWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157 · cited 1×
“The mechanism mediating AMPK activation is still largely unknown, although it has been postulated that the biguanides may inhibit complex I of the mitochondrial respiratory chain with subsequent increases in the intracellular AMP : ATP ratio (El-Mir et al. 2000, Owen et al. 2000).”
BackgroundThe Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
Shaw, R. J., Lamia, K. A., Vasquez, D., Koo, S.-H., Bardeesy, N., DePinho, R. A., Montminy, M., & Cantley, L. C. (2005) · Science · doi:10.1126/science.1120781 · Cited by 1,950 · cited 3×
“Deletion of hepatic LKB1 resulted in hyperglycaemia, attributed to increased lipogenic and gluconeogenic gene expression and the ablation of metformin’s effects on AMPK activation and plasma glucose (Shaw et al. 2005).”
BackgroundLKB1 is the upstream kinase in the AMP-activated protein kinase cascade
Woods, A., Johnstone, S. R., Dickerson, K., Leiper, F. C., Fryer, L. G. D., Neumann, D., Schlattner, U., Wallimann, T., Carlson, M., & Carling, D. (2003) · Current Biology · doi:10.1016/j.cub.2003.10.031 · Cited by 1,650
The Mitochondrial Carnitine Palmitoyltransferase System — From Concept to Molecular Analysis
McGarry, J. D., & Brown, N. F. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00001.x · Cited by 1,616 · cited 1×
“…by decreasing malonylCoA concentrations through inhibiting ACC and activating MCD. Malonyl-CoA is a potent allosteric inhibitor of carnitine palmitoryltransferase-1 (CPT1), the rate-limiting enzyme that transfers long-chain acyl-CoA into mitochondria for b-oxidation (McGarry & Brown 1997).”
BackgroundHawley, S. A., Pan, D. A., Mustard, K. J., Ross, L., Bain, J., Edelman, A. M., Frenguelli, B. G., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.009 · Cited by 1,589 · cited 1×
“Thr172 of the a subunit is phosphorylated by the tumour suppressor kinase LKB1 (Hawley et al. 2003, Woods et al. 2003) and calmodulin-dependent protein kinase-b (CaMKKb) (Hawley et al. 2005, Hurley et al. 2005, Woods et al. 2005) resulting in activation of the enzyme.”
BackgroundEl-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399 · cited 1×
“The mechanism mediating AMPK activation is still largely unknown, although it has been postulated that the biguanides may inhibit complex I of the mitochondrial respiratory chain with subsequent increases in the intracellular AMP : ATP ratio (El-Mir et al. 2000, Owen et al. 2000).”
BackgroundKrssak, M., Falk Petersen, K., Dresner, A., DiPietro, L., Vogel, S. M., Rothman, D. L., Shulman, G. I., & Roden, M. (1999) · Diabetologia · doi:10.1007/s001250051123 · Cited by 1,264 · cited 1×
“However, recent studies with ob/ob mice deficient in adiponectin suggest that while effects on hepatic GNG may well be mediated by adiponectin, TZDs have adiponectinindependent effects that contribute to skeletal muscle glucose uptake (Kubota et al. 2006).”
Background
Cited by
Salminen, A., Hyttinen, J. M. T., & Kaarniranta, K. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0748-0 · Cited by 866
AMP-Activated Protein Kinase (AMPK) Controls the Aging Process via an Integrated Signaling Network
Salminen, A., & Kaarniranta, K. (2012) · Ageing Research Reviews · doi:10.1016/j.arr.2011.12.005 · Cited by 860
The emerging role of autophagy in the pathophysiology of diabetes mellitus
Gonzalez, C. D., Lee, M.-S., Marchetti, P., Pietropaolo, M., Towns, R., Vaccaro, M. I., Watada, H., & Wiley, J. W. (2011) · Autophagy · doi:10.4161/auto.7.1.13044 · Cited by 317
Srivastava, R. A. K., Pinkosky, S. L., Filippov, S., Hanselman, J. C., Cramer, C. T., & Newton, R. S. (2012) · Journal of Lipid Research · doi:10.1194/jlr.r025882 · Cited by 296
Metformin activation of AMPK suppresses AGE-induced inflammatory response in hNSCs
Chung, M.-M., Nicol, C. J., Cheng, Y.-C., Lin, K.-H., Chen, Y.-L., Pei, D., Lin, C.-H., Shih, Y.-N., Yen, C.-H., Chen, S.-J., et al. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.01.017 · Cited by 66
Metadata
- Authors
- Zhou, G., Sebhat, I. K., & Zhang, B. B.
- Venue
- Acta Physiologica
- Publisher
- Wiley
- Published
- 2009-04
- Volume
- 196
- Issue
- 1
- Pages
- 175-190
- ISSN
- 1748-1708 (ISSN-L)
- 1748-1716
- OpenAlex
- W2025056866
- Cited by
- 63
- References
- 38
- FWCI
- 3.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: AMPK activators – potential therapeutics for metabolic and other diseases. https://app.cochat.ai/papers/10.1111/j.1748-1716.2009.01967.x
- The paper
- Zhou, G., Sebhat, I. K., & Zhang, B. B. (2009). AMPK activators – potential therapeutics for metabolic and other diseases. Acta Physiologica. https://doi.org/10.1111/j.1748-1716.2009.01967.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.